Narrow search
Showing 1 - 10 of 24
Cover Image
Direkte und indirekte Kosten von Krankheiten in der Bundesrepublik Deutschland 1980 bis 1990
Henke, Klaus-Dirk; Martin, Karl; Behrens, Cornelia S. - 1997
Persistent link: https://www.econbiz.de/10000952374
Cover Image
Cost-sharing in the German health care system
Gericke, Christian A.; Wismar, Matthias; Busse, Reinhard - 2004
Persistent link: https://www.econbiz.de/10001988257
Cover Image
Defining benefit catalogues and entitlements to health care in Germany : decision makers, decision criteria and taxonomy of catalogues
Busse, Reinhard; Stargardt, Tom; Schreyögg, Jonas; … - 2005
Persistent link: https://www.econbiz.de/10002843907
Cover Image
Soziale Gesundheitswirtschaft : Ordnungsrahmen für ein zukunftsfähiges Gesundheitssystem
Henke, Klaus-Dirk - 2009
Persistent link: https://www.econbiz.de/10003898612
Cover Image
The social health economy : s regulatory framework for a healthcare system to meet the challenges of the future
Henke, Klaus-Dirk; Lohmann, Heinz; Straub, Christoph; … - 2009
Persistent link: https://www.econbiz.de/10003918285
Cover Image
Measuring the relationship between costs and outcomes : the example of Acute Myocardial Infarction in German hospitals
Stargardt, Tom; Schreyögg, Jonas; Kondofersky, Ivan - 2012
In this paper, we propose a methodological approach to measure the relationship between hospital costs and health outcomes. We propose to investigate the relationship for each condition or disease area using patient-level data. We suggest to examine health outcomes as a function of costs and...
Persistent link: https://www.econbiz.de/10009633487
Cover Image
Towards sustainable health care systems : strategies in health insurance schemes in France, Germany, Japan and the Netherlands ; a comparative study
Henke, Klaus-Dirk; Schreyögg, Jonas - 2004
compares the health care systems of France, Germany, Japan and the Netherlands. Due to the complexity of the different …
Persistent link: https://www.econbiz.de/10009492624
Cover Image
Managing pharmaceutical regulation in Germany : overview and economic assessment
Schreyögg, Jonas; Henke, Klaus-Dirk; Busse, Reinhard - 2004
Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years …. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both …
Persistent link: https://www.econbiz.de/10009492625
Cover Image
Cost-sharing in the German health care system
Gericke, Christian A.; Wismar, Matthias; Busse, Reinhard - 2004
In Germany, cost-sharing for health care has been used as a financing mechanism since 1923. In this article, the … historical development of user charges in Germany since the 1980s is presented in more detail by type of private expenditure … of cost-sharing on equity, efficiency and health outcomes in Germany are presented. …
Persistent link: https://www.econbiz.de/10009499934
Cover Image
Perspektiven der molekularen Diagnostik für public health und die Gesundheitswirtschaft : eine Literaturstudie
Martin, Karl; Henke, Klaus-Dirk - 2007
Als Molekulare Diagnostik werden alle diagnostischen Methoden verstanden, die auf der Grundlage molekularer oder biochemischer Analysen in vivo (im lebenden Organismus) und in vitro (im Versuch, außerhalb des Organismus) gemacht werden. Die nachfolgende Studie beschränkt sich auf die in vitro...
Persistent link: https://www.econbiz.de/10009500542